Author: Laura Loughlin

KCCure – Making a Difference – Calithera Biosciences

Kidney Cancer clinical trials provide an exciting opportunity to be at the forefront of cancer treatment. In this Making a Difference article, KCCure highlights the work being done by Calithera Biosciences.  Laura Loughlin, KCCure’s Director of Patient Engagement, had the opportunity to speak with Catherine Sunderlin, Senior Medical Science Liaison at Calithera Biosciences to discuss their C...

KCCure – Finding Quality of Life – Palliative Care

In the making a difference series, KCCure’s Director of Patient Engagement, Laura Loughlin, shares how connecting with palliative care improved her quality of life during radiation treatment, and explores how palliative care services can improve the quality of life for both patients and their families. When I was first diagnosed in 2016 with stage 4 RCC an oncologist told me that from that point f...

Making a Difference – Rare Kidney Cancer Research

In the making a difference series, KCCure’s Director of Patient Engagement, Laura Loughlin, will be highlighting organizations making a difference in Kidney Cancer research. In this article we are profiling the work being done at The Rare Cancer Research Foundation (RCRF), with focus on their patient directed consent platform Pattern.org. The Rare Cancer Research Foundation (RCRF) is a 501(c)3 non...

Making a Difference – The Broad Institute

In the Making a Difference series, KCCure’s Director of Patient Engagement, Laura Loughlin will be highlighting organizations making a difference in Kidney Cancer research.  In this first article, we’re profiling work being done at the Broad Institute researching rare kidney cancer. The Broad Institute of Cambridge and Harvard Located in Cambridge, MA the Broad is a non-profit research...

Gene Therapy – An RCC Clinical Trial at the NIH

KCCure highlights new and exciting research in kidney cancer at the NIH as well as an RCC clinical trial that is open now for kidney cancer patients.

Lost Password

Register

Subscribe for updates!